In fact, several studies showed that inhibition of Bcl-2 sensitizes tumor cells toward ionizing radiation (Zerp et al. 2009; Moretti et al. 2010), revealing that Bcl-2 and, possibly, other members of this protein family may serve as candidates for targeted approaches in the future. The gene discussed is BCL2; the disease is neoplasm.